Control Bionics (ASX:CBL) Accounts Payable: A$1.71 Mil (As of Dec. 2025)


What is Control Bionics Accounts Payable?

Control Bionics ASX:CBL +1.35% Accounts Payable is A$1.71 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Control Bionics's Accounts Payable for the quarter that ended in Dec. 2025 was A$1.71 Mil.

Control Bionics's quarterly Accounts Payable declined from Dec. 2024 (A$1.68 Mil) to Jun. 2025 (A$0.88 Mil) but then increased from Jun. 2025 (A$0.88 Mil) to Dec. 2025 (A$1.71 Mil).

Control Bionics's annual Accounts Payable increased from Jun. 2023 (A$0.52 Mil) to Jun. 2024 (A$0.61 Mil) and increased from Jun. 2024 (A$0.61 Mil) to Jun. 2025 (A$0.88 Mil).

Control Bionics Accounts Payable Related Terms

Control Bionics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Control Bionics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Control Bionics Accounts Payable Chart

Control Bionics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial 0.46 0.43 0.52 0.61 0.88

Control Bionics Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 0.61 1.68 0.88 1.71

Control Bionics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of A$1.71 Mil mean?
Control Bionics (ASX:CBL) has a Accounts Payable of A$1.71 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Control Bionics and its competitors.
Is Control Bionics' Accounts Payable too high?
Control Bionics' current Accounts Payable is A$1.71 Mil.
How does Control Bionics' Accounts Payable compare to ABT and SYK?
Control Bionics' Accounts Payable of A$1.71 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Control Bionics and its competitors. Control Bionics's current Accounts Payable is A$1.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Control Bionics stock overvalued right now?
Based on GuruFocus' analysis, Control Bionics (ASX:CBL) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.08 — trading 150% above its estimated fair value. The current Accounts Payable is A$1.71 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Control Bionics (ASX:CBL), the current Accounts Payable is A$1.71 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Control Bionics Business Description

Address 11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically, it derives a majority of revenue from North America and has its presence in Australia as well.